Jan Harder

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

Anja Rinke, Hans‐Helge Müller, Carmen Schade‐Brittinger et al. · Journal of Clinical Oncology · 2009 · 2.5K citations

Phase I Clinical Study of AZD2171, an Oral Vascular Endothelial Growth Factor Signaling Inhibitor, in Patients With Advanced Solid Tumors

Joachim Drevs, Patrizia Siegert, Michael Medinger et al. · Journal of Clinical Oncology · 2007 · 302 citations

Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

Jan Harder, Gabriele Ihorst, Volker Heinemann et al. · British Journal of Cancer · 2012 · 180 citations · Full text

Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer

Jan Harder, Bettina Riecken, Oliver Kummer et al. · British Journal of Cancer · 2006 · 122 citations · Full text

Surgical Oncology, Oncology, Urology +15

Treatment of unresectable cholangiocarcinoma

Jan Kuhlmann, Wulf Euringer, Hans Christian Spangenberg et al. · European Journal of Gastroenterology & Hepatology · 2012 · 120 citations · Full text